SCHEMBL31268853

SCHEMBL31268853

Cc1ccnc(Cn2c(-c3ccc(C(=O)NC4CC(F)C4)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 2/20 0.35
▸ CNR1 P21554 7/20 0.35
▸ CNR2 P34972 5/20 0.35
▸ PIK3CD O00329 3/20 0.34
▸ GRM5 P41594 1/20 0.33
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ KCNH2 Q12809 1/20 0.30
▸ SCN5A Q14524 1/20 0.30
▸ SCN9A Q15858 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ GLA P06280 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ CTDSP1 Q9GZU7 1/20 0.30
▸ CCNA2 P20248 1/20 0.30
▸ CDK2 P24941 1/20 0.30
▸ CDK5 Q00535 1/20 0.30
▸ CDK5R1 Q15078 1/20 0.30
▸ AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269247 0.94 PIK3CD (0.34) CNR1CNR2PIK3CDGRM5MEN1
SCHEMBL31269185 0.93 CNR1 (0.38) PDE4BCNR1CNR2PIK3CDGRM5
SCHEMBL31269264 0.91 ABL1 (0.35) CNR1CNR2PIK3CDGRM5MEN1
SCHEMBL31268823 0.89 ABL1 (0.38) CNR1CNR2PIK3CDKMT2A
SCHEMBL31269416 0.89 PIK3CD (0.33) PDE4BPIK3CD
SCHEMBL31269478 0.89 SYK (0.36) PIK3CDKCNH2SCN5ASCN9A
SCHEMBL31269475 0.88 PIK3CD (0.37) PIK3CDKCNH2SCN5ASCN9A
SCHEMBL31268954 0.87 PIK3CD (0.35) PIK3CDMEN1KMT2A
SCHEMBL31269058 0.87 PIK3CD (0.36) CNR1CNR2PIK3CDKCNH2SCN5A
SCHEMBL31268793 0.87 PIK3CD (0.35) CNR1CNR2PIK3CDKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback